
Penumbra PEN
$ 340.3
0.46%
Quarterly report 2025-Q3
added 11-05-2025
Country |
|
IPO year |
2015 |
Industry |
Medical devices |
Stock Exchange |
NYSESPB |
Shares |
38.6 M |
Market Cap[1] |
$ 13.1 B |
EBITDA (LTM) |
$ 171 M |
P/E (LTM) |
82.29 |
P/S (LTM) |
9.93 |
EPS (LTM) |
4.12 |
Other stocks of industry "Medical devices"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
AxoGen
AXGN
|
$ 33.35 | 2.25 % | $ 1.48 B | Nasdaq Capital Market,SPB | ||
|
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | ||
|
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | ||
|
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | ||
|
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | ||
|
Acutus Medical
AFIB
|
- | -26.83 % | $ 2.62 M | Nasdaq Global Select Market | ||
|
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market | ||
|
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | ||
|
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | Nasdaq Global Market | ||
|
Cognyte Software Ltd.
CGNT
|
$ 7.09 | 3.2 % | $ 509 M | Nasdaq Global Select Market,SPB | ||
|
Apyx Medical Corporation
APYX
|
$ 3.85 | 0.79 % | $ 133 M | Nasdaq Global Select Market | ||
|
Alphatec Holdings
ATEC
|
$ 13.41 | 2.33 % | $ 1.92 B | Nasdaq Global Select Market | ||
|
BIOLASE
BIOL
|
- | -13.19 % | $ 166 K | Nasdaq Capital Market | ||
|
Bio-Rad Laboratories
BIO
|
$ 259.84 | -10.91 % | $ 7.33 B | NYSE,SPB | ||
|
Conformis
CFMS
|
- | - | $ 16.4 M | Nasdaq Capital Market | ||
|
Bruker Corporation
BRKR
|
$ 36.2 | -3.51 % | $ 5.39 K | Nasdaq Global Select Market,SPB | ||
|
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market | ||
|
CONMED Corporation
CNMD
|
$ 42.01 | 0.74 % | $ 1.3 B | NYSE,SPB | ||
|
Boston Scientific Corporation
BSX
|
$ 75.35 | 1.66 % | $ 111 B | NYSE,SPB | ||
|
Abbott Laboratories
ABT
|
$ 112.29 | 0.73 % | $ 195 B | NYSE,SPB | ||
|
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | Nasdaq Global Select Market,SPB | ||
|
Delcath Systems
DCTH
|
$ 9.37 | 2.74 % | $ 267 M | Nasdaq Capital Market | ||
|
Cutera
CUTR
|
- | -10.19 % | $ 1.99 M | Nasdaq Global Select Market | ||
|
CryoLife, Inc.
CRY
|
- | -4.14 % | $ 702 M | NYSE,SPB | ||
|
EDAP TMS S.A.
EDAP
|
$ 4.79 | 0.42 % | $ 179 M | Nasdaq Global Market | ||
|
ClearPoint Neuro
CLPT
|
$ 13.81 | 5.9 % | $ 373 M | Nasdaq Capital Market | ||
|
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | ||
|
Electromed
ELMD
|
$ 23.82 | 2.21 % | $ 201 M | NYSE American | ||
|
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | ||
|
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market | ||
|
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | Nasdaq Capital Market | ||
|
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | ||
|
Neovasc
NVCN
|
- | - | $ 111 M | Nasdaq Capital Market | ||
|
Intersect ENT, Inc.
XENT
|
- | - | $ 955 M | Nasdaq Global Market | ||
|
Eargo
EAR
|
- | - | $ 10.2 M | Nasdaq Global Select Market,SPB | ||
|
Inogen
INGN
|
$ 5.88 | 1.52 % | $ 139 M | Nasdaq Global Select Market,SPB | ||
|
InMode Ltd.
INMD
|
$ 14.32 | 0.14 % | $ 1.14 B | Nasdaq Global Select Market,SPB | ||
|
GBS
GBS
|
- | -0.57 % | $ 7.12 M | Nasdaq Global Market | ||
|
IRadimed Corporation
IRMD
|
$ 101.26 | 1.42 % | $ 1.28 B | Nasdaq Global Select Market | ||
|
Integer Holdings Corporation
ITGR
|
$ 85.84 | 0.68 % | $ 2.88 B | NYSE,SPB | ||
|
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | Nasdaq Capital Market | ||
|
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | ||
|
FONAR Corporation
FONR
|
$ 18.54 | - | $ 122 M | Nasdaq Capital Market | ||
|
Globus Medical
GMED
|
$ 89.17 | 2.24 % | $ 12.1 B | NYSE,SPB | ||
|
Pulmonx Corporation
LUNG
|
$ 1.49 | 4.93 % | $ 58.3 M | Nasdaq Global Select Market | ||
|
Integra LifeSciences Holdings Corporation
IART
|
$ 11.52 | 6.57 % | $ 887 M | Nasdaq Global Select Market,SPB | ||
|
Myomo
MYO
|
$ 0.81 | 1.15 % | $ 5.71 M | NYSE American | ||
|
Establishment Labs Holdings
ESTA
|
$ 72.85 | -0.94 % | $ 2.05 B | Nasdaq Capital Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.